Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Mersana Therapeutics - Stock Price History | MRSN

Historical daily share price chart and data for Mersana Therapeutics since 2020 adjusted for splits. The latest closing stock price for Mersana Therapeutics as of August 07, 2020 is 20.27.
  • The all-time high Mersana Therapeutics stock closing price was 23.40 on June 30, 2020.
  • The Mersana Therapeutics 52-week high stock price is 24.97, which is 23.2% above the current share price.
  • The Mersana Therapeutics 52-week low stock price is 1.32, which is 93.5% below the current share price.
  • The average Mersana Therapeutics stock price for the last 52 weeks is 8.52.
  
Mersana Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 3.8775 4.3100 7.3000 1.4500 5.7300 40.44%
2018 13.2677 17.3900 22.6800 3.4500 4.0800 -75.17%
2017 16.5393 14.0000 19.9000 13.2700 16.4300 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.357B $0.042B
Mersana Therapeutics, Inc. is a biotechnology company. It focused on discovering and developing a pipeline of antibody drug conjugates. The company's product candidates include XMT-1522 and XMT-1536 which are in clinical stage. Mersana Therapeutics, Inc. is based in CAMBRIDGE, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.971B 15.31
Bristol Myers Squibb (BMY) United States $138.069B 10.63
CSL (CSLLY) Australia $89.402B 0.00
Gilead Sciences (GILD) United States $86.946B 12.52
Vertex Pharmaceuticals (VRTX) United States $71.105B 39.68
Regeneron Pharmaceuticals (REGN) United States $68.234B 25.23
Illumina (ILMN) United States $52.282B 60.38
Biogen (BIIB) United States $48.398B 8.28
Moderna (MRNA) United States $29.239B 0.00
Seattle Genetics (SGEN) United States $27.918B 0.00
Genmab (GMAB) Denmark $23.865B 19.63
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $23.603B 0.00
Alexion Pharmaceuticals (ALXN) United States $22.636B 9.43
Genmab (GNMSF) Denmark $22.579B 67.04
BioMarin Pharmaceutical (BMRN) United States $21.521B 156.15
Incyte (INCY) United States $21.199B 0.00
BeiGene (BGNE) Cayman Islands $19.703B 0.00
BioNTech SE (BNTX) Germany $17.422B 0.00
Alnylam Pharmaceuticals (ALNY) United States $16.645B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.703B 36.74
Bio-Rad Laboratories (BIO.B) United States $15.581B 70.47
Exact Sciences (EXAS) United States $13.018B 0.00
Sarepta Therapeutics (SRPT) United States $12.480B 0.00
Galapagos (GLPG) Belgium $12.446B 36.61
ARGENX SE-ADR (ARGX) Netherlands $10.848B 0.00
QIAGEN (QGEN) Netherlands $10.775B 27.35
Bio-Techne Corp (TECH) United States $10.158B 70.31
Immunomedics (IMMU) United States $9.928B 0.00
Novavax (NVAX) United States $9.870B 0.00
Guardant Health (GH) United States $8.512B 0.00
Repligen (RGEN) United States $8.021B 127.31
Ascendis Pharma (ASND) Denmark $7.714B 0.00
Emergent Biosolutions (EBS) United States $6.915B 27.39
Exelixis (EXEL) United States $6.909B 25.12
ACADIA Pharmaceuticals (ACAD) United States $6.738B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.302B 195.24
SWEDISH ORP BIO (BIOVF) Sweden $6.177B 15.37
Vir Biotechnology (VIR) United States $6.134B 0.00
Acceleron Pharma (XLRN) United States $5.937B 0.00
Mirati Therapeutics (MRTX) United States $5.740B 0.00
MyoKardia (MYOK) United States $5.481B 0.00
Reata Pharmaceuticals (RETA) United States $5.192B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.140B 0.00
Adaptive Biotechnologies (ADPT) United States $4.901B 0.00
Zai Lab (ZLAB) China $4.669B 0.00
NeoGenomics (NEO) United States $4.382B 1322.67
Bluebird Bio (BLUE) United States $4.204B 0.00
China Biologic Products (CBPO) China $4.176B 23.21
Blueprint Medicines (BPMC) United States $4.115B 0.00
MorphoSys AG (MOR) Germany $4.105B 53.79
Amicus Therapeutics (FOLD) United States $3.971B 0.00
Halozyme Therapeutics (HALO) United States $3.935B 0.00
Global Blood Therapeutics (GBT) United States $3.916B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.883B 0.00
Arena Pharmaceuticals (ARNA) United States $3.647B 0.00
Sorrento Therapeutics (SRNE) United States $3.490B 0.00
Denali Therapeutics (DNLI) United States $3.339B 0.00
Inovio Pharmaceuticals (INO) United States $3.197B 0.00
Insmed (INSM) United States $3.120B 0.00
Principia Biopharma (PRNB) United States $3.052B 0.00
Alkermes (ALKS) Ireland $2.973B 62.32
Fate Therapeutics (FATE) United States $2.938B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.757B 0.00
Amarin (AMRN) Ireland $2.698B 0.00
Twist Bioscience (TWST) United States $2.527B 0.00
Editas Medicine (EDIT) United States $1.917B 0.00
PHARMA MAR SA (PHMMF) Spain $1.908B 0.00
Viela Bio (VIE) United States $1.902B 0.00
Ligand Pharmaceuticals (LGND) United States $1.888B 63.95
Mesoblast (MESO) Australia $1.874B 0.00
UniQure (QURE) Netherlands $1.836B 0.00
Sangamo Therapeutics (SGMO) United States $1.738B 0.00
Revance Therapeutics (RVNC) United States $1.718B 0.00
I-Mab (IMAB) China $1.716B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.682B 40.04
Intercept Pharmaceuticals (ICPT) United States $1.606B 0.00
Eidos Therapeutics (EIDX) United States $1.591B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.566B 0.00
Adverum Biotechnologies (ADVM) United States $1.482B 0.00
Zymeworks (ZYME) Canada $1.410B 0.00
Coherus BioSciences (CHRS) United States $1.403B 8.18
Intra-Cellular Therapies (ITCI) United States $1.389B 0.00
Zealand Pharma (ZEAL) Denmark $1.371B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.362B 0.00
Epizyme (EPZM) United States $1.306B 0.00
NGM Biopharmaceuticals (NGM) United States $1.289B 0.00
Cytokineticsorporated (CYTK) United States $1.279B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
REGENXBIO (RGNX) United States $1.233B 0.00
Beam Therapeutics (BEAM) United States $1.208B 0.00
Alcobra (ARCT) United States $1.185B 0.00
Akcea Therapeutics (AKCA) United States $1.179B 0.00
Alector (ALEC) United States $1.174B 0.00
Intellia Therapeutics (NTLA) United States $1.165B 0.00
Arvinas (ARVN) United States $1.127B 0.00
Compugen (CGEN) Israel $1.117B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.051B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.038B 0.00
NantKwest (NK) United States $1.036B 0.00
Arcus Biosciences (RCUS) United States $1.002B 0.00
Heska (HSKA) United States $0.986B 0.00
VBI Vaccines (VBIV) United States $0.981B 0.00
Retrophin (RTRX) United States $0.977B 0.00
Myriad Genetics (MYGN) United States $0.909B 46.88
Athenex (ATNX) United States $0.900B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.860B 0.00
Dynavax Technologies (DVAX) United States $0.852B 0.00
Intrexon (PGEN) United States $0.840B 0.00
Codexis (CDXS) United States $0.812B 0.00
Cara Therapeutics (CARA) United States $0.793B 0.00
Morphic Holding (MORF) United States $0.778B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 17.14
Cellectis S.A (CLLS) France $0.743B 0.00
Kadmon Holdings (KDMN) United States $0.727B 0.00
Castle Biosciences (CSTL) United States $0.720B 0.00
Vericel (VCEL) United States $0.712B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.711B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.704B 0.00
Frequency Therapeutics (FREQ) United States $0.673B 0.00
MiMedx (MDXG) United States $0.663B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.656B 5.74
Agenus (AGEN) United States $0.643B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Syndax Pharmaceuticals (SNDX) United States $0.611B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
Cue Biopharma (CUE) United States $0.565B 0.00
Syros Pharmaceuticals (SYRS) United States $0.558B 0.00
MeiraGTx Holdings (MGTX) United States $0.516B 0.00
Athersys (ATHX) United States $0.515B 0.00
Prothena (PRTA) Ireland $0.508B 0.00
AnaptysBio (ANAB) United States $0.504B 0.00
Kala Pharmaceuticals (KALA) United States $0.500B 0.00
Protagonist Therapeutics (PTGX) United States $0.493B 0.00
Anika Therapeutics (ANIK) United States $0.489B 21.41
UROGEN PHARMA (URGN) United States $0.484B 0.00
Innate Pharma S.A (IPHA) France $0.471B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.459B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.456B 0.00
AC Immune SA (ACIU) Switzerland $0.454B 0.00
BioDelivery Sciences (BDSI) United States $0.453B 32.07
Prometic Life Sciences (LMNL) Canada $0.437B 0.00
Avid Bioservices (CDMO) United States $0.437B 0.00
Scholar Rock Holding (SRRK) United States $0.420B 0.00
Clovis Oncology (CLVS) United States $0.417B 0.00
Puma Biotechnology (PBYI) United States $0.407B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.392B 0.00
Kamada (KMDA) Israel $0.387B 16.11
Merus (MRUS) Netherlands $0.385B 0.00
ANI Pharmaceuticals (ANIP) United States $0.374B 8.83
Albireo Pharma (ALBO) United States $0.372B 0.00
MannKind (MNKD) United States $0.364B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.362B 0.00
PDL BioPharma (PDLI) United States $0.360B 0.00
Precision BioSciences (DTIL) United States $0.359B 0.00
Seres Therapeutics (MCRB) United States $0.354B 0.00
CytomX Therapeutics (CTMX) United States $0.352B 0.00
Geron (GERN) United States $0.342B 0.00
WAVE Life Sciences (WVE) Singapore $0.327B 0.00
Biofrontera AG (BFRA) Germany $0.326B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.311B 0.00
ChromaDex (CDXC) United States $0.307B 0.00
Starpharma Holdings (SPHRY) Australia $0.293B 0.00
Affimed (AFMD) Germany $0.290B 0.00
Selecta Biosciences (SELB) United States $0.284B 0.00
OSMOTICA PHARM (OSMT) United States $0.284B 0.00
Cellular Biomedicine (CBMG) United States $0.280B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.279B 0.00
Spero Therapeutics (SPRO) United States $0.275B 0.00
Menlo Therapeutics (MNLO) United States $0.271B 0.00
NextCure (NXTC) United States $0.263B 0.00
Arbutus Biopharma (ABUS) United States $0.262B 0.00
Northwest Biotherapeutics (NWBO) United States $0.258B 0.00
Trevena (TRVN) United States $0.255B 0.00
Fortress Biotech (FBIO) United States $0.252B 0.00
Celldex Therapeutics (CLDX) United States $0.251B 0.00
ADMA Biologics Inc (ADMA) United States $0.250B 0.00
DBV Technologies S.A (DBVT) France $0.248B 0.00
Dyadic (DYAI) United States $0.244B 0.00
Verastem (VSTM) United States $0.241B 0.00
Abeona Therapeutics (ABEO) United States $0.239B 0.00
HOOKIPA Pharma (HOOK) United States $0.235B 0.00
Pluristem Therapeutics (PSTI) Israel $0.229B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.228B 0.00
IVERIC Bio (ISEE) United States $0.227B 0.00
Strongbridge Biopharma (SBBP) United States $0.217B 0.00
Cerecor (CERC) United States $0.213B 0.00
Exicure (XCUR) United States $0.209B 0.00
Aduro Biotech (ADRO) United States $0.207B 0.00
Five Prime Therapeutics (FPRX) United States $0.206B 0.00
Sutro Biopharma (STRO) United States $0.199B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.198B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.197B 9.20
GENFIT S.A (GNFT) France $0.193B 0.00
Theratechnologies (THTX) Canada $0.189B 0.00
XOMA (XOMA) United States $0.181B 0.00
Aptinyx (APTX) United States $0.180B 0.00
POXEL SA FRANCE (PXXLF) France $0.177B 0.00
Liquidia Technologies (LQDA) United States $0.176B 0.00
VTv Therapeutics (VTVT) United States $0.173B 0.00
Aytu Bioscience (AYTU) United States $0.166B 0.00
Bellus Health (BLU) Canada $0.166B 0.00
Kindred Biosciences (KIN) United States $0.165B 0.00
Cidara Therapeutics (CDTX) United States $0.160B 0.00
TELA Bio (TELA) United States $0.151B 0.00
Cyclerion Therapeutics (CYCN) United States $0.148B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Celyad SA (CYAD) Belgium $0.143B 0.00
Applied Genetic Technologies (AGTC) United States $0.142B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.141B 0.00
Eton Pharmaceuticals (ETON) United States $0.139B 0.00
Gritstone Oncology (GRTS) United States $0.139B 0.00
Checkpoint Therapeutics (CKPT) United States $0.127B 0.00
Windtree Therapeutics (WINT) United States $0.126B 0.00
Lumos Pharma (LUMO) United States $0.125B 0.00
Orgenesis (ORGS) United States $0.124B 6.29
Cardiff Oncology (CRDF) United States $0.122B 0.00
Enzo Biochem (ENZ) United States $0.121B 0.00
Oncobiologics (OTLK) United States $0.119B 0.00
PHASEBIO PHARMA (PHAS) United States $0.117B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.117B 0.00
SESEN BIO, INC (SESN) United States $0.110B 0.00
Cocrystal Pharma (COCP) United States $0.106B 0.00
Antibe Therapeutics (ATBPF) Canada $0.103B 0.00
Vaccinex (VCNX) United States $0.099B 0.00
ARAVIVE, INC (ARAV) United States $0.097B 0.00
Organovo Holdings (ONVO) United States $0.093B 0.00
AIT Therapeutics (XAIR) United States $0.091B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.088B 0.00
AnPac Bio-Medical Science (ANPC) China $0.085B 0.00
Unum Therapeutics (UMRX) United States $0.084B 0.00
Emmaus Life Sciences (EMMA) United States $0.081B 0.00
AquaBounty Technologies (AQB) United States $0.081B 0.00
Adocia (ADOCY) France $0.080B 0.00
Clearside Biomedical (CLSD) United States $0.079B 0.00
DiaMedica Therapeutics (DMAC) United States $0.077B 0.00
Ecology Coatings (ABVC) United States $0.074B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.074B 0.00
Idera Pharmaceuticals (IDRA) United States $0.074B 0.00
Synlogic (SYBX) United States $0.073B 0.00
Bionano Genomics (BNGO) United States $0.072B 0.00
Proteostasis Therapeutics (PTI) United States $0.071B 0.00
Edesa Biotech (EDSA) Canada $0.071B 0.00
Stealth BioTherapeutics (MITO) United States $0.067B 96.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.066B 0.00
Soligenix (SNGX) United States $0.065B 0.00
Catalyst Biosciences (CBIO) United States $0.065B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.065B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.065B 0.00
Signal Genetics (MGEN) United States $0.062B 0.00
IMMURON (IMRN) Australia $0.061B 0.00
Happiness Biotech Group (HAPP) China $0.060B 0.00
Genetic Technologies (GENE) Australia $0.056B 0.00
Vascular Biogenics (VBLT) Israel $0.055B 0.00
CollPlant Holdings (CLGN) Israel $0.054B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.053B 0.00
Curis (CRIS) United States $0.052B 0.00
Prima BioMed (IMMP) Australia $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.049B 0.00
Novogen (KZIA) Australia $0.046B 0.00
Spherix (AIKI) United States $0.041B 0.00
Cesca Therapeutics (THMO) United States $0.039B 0.00
Celsion (CLSN) United States $0.038B 0.00
ATyr Pharma (LIFE) United States $0.037B 0.00
Prana Biotechnology (ATHE) Australia $0.037B 0.00
OvaScience (MLND) United States $0.036B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.035B 0.00
Advaxis (ADXS) United States $0.034B 0.00
Forte Biosciences (FBRX) United States $0.033B 0.00
Pulmatrix (PULM) United States $0.032B 0.00
Alimera Sciences (ALIM) United States $0.032B 0.00
Cleveland BioLabs (CBLI) United States $0.032B 0.00
Evogene (EVGN) Israel $0.031B 0.00
Chanticleer Holdings (SONN) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.023B 0.00
MYOS RENS Technology (MYOS) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
BioCardia (BCDA) United States $0.018B 0.00
Neuralstem (SNCA) United States $0.015B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00